Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever)

Contemporary Clinical Trials Communications(2021)10.1016/j.conctc.2021.100851Source: DataRank Database

A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever) is a research paper published in Contemporary Clinical Trials Communications (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.57)OA: goldTopics (19)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Eileen K Maziarz ORCID,John N. Galgiani ORCID,Jonathan Truong,Aung Htoo,Arash Heidari ORCID

Live enrichment

PubMed:34712863 PMC:PMC8528682 OpenAlex:https://openalex.org/W3205555302

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Grant: HHSN272201300017I

NIAID NIH HHS

Grant: T32 AI100851

National Institutes of Health

National Institute of Allergy and Infectious Diseases

U.S. Department of Health and Human Services

FWCI

0.57

Citation Percentile

0.7%

Citation Trend

2022

2023

2025

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S2451865421001514/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2451865421001514/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2451865421001514?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451865421001514?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.conctc.2021.100851

Fields of Study

Fungal Infections and StudiesAntifungal resistance and susceptibilityNail Diseases and Treatments

Keywords

FluconazoleMedicinePlaceboCommunity-acquired pneumoniaPneumoniaClinical trialInternal medicineEmpiric therapyRandomized controlled trialCoccidioides immitisIntensive care medicinePediatricsAntifungalPathologyCoccidioidomycosisValley Fever

Sustainable Development Goals

SDG 0: Good health and well-being

A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever)

FAIR Checklist

Authors (16)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)